keyword
https://read.qxmd.com/read/38593070/structure-and-design-of-langya-virus-glycoprotein-antigens
#41
JOURNAL ARTICLE
Zhaoqian Wang, Matthew McCallum, Lianying Yan, Cecily A Gibson, William Sharkey, Young-Jun Park, Ha V Dang, Moushimi Amaya, Ashley Person, Christopher C Broder, David Veesler
Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) glycoproteins which are the main targets of neutralizing antibodies. We show here that the LayV F and G glycoproteins promote membrane fusion with human, mouse, and hamster target cells using a different, yet unknown, receptor than Nipah virus (NiV) and Hendra virus (HeV) and that NiV- and HeV-elicited monoclonal and polyclonal antibodies do not cross-react with LayV F and G...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38590754/altered-covid-19-immunity-in-children-with-asthma-by-atopic-status
#42
JOURNAL ARTICLE
Sherry Tong, Jordan C Scott, Enwono Eyoh, Derek W Werthmann, Addison E Stone, Amelie E Murrell, Gilberto Sabino-Santos, Ivy V Trinh, Sruti Chandra, Debra H Elliott, Ashley R Smira, Jalene V Velazquez, John Schieffelin, Bo Ning, Tony Hu, Jay K Kolls, Samuel J Landry, Kevin J Zwezdaryk, James E Robinson, Bronwyn M Gunn, Felicia A Rabito, Elizabeth B Norton
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a spectrum of clinical outcomes that may be complicated by severe asthma. Antiviral immunity is often compromised in patients with asthma; however, whether this is true for SARS-CoV-2 immunity and children is unknown. OBJECTIVE: We aimed to evaluate SARS-CoV-2 immunity in children with asthma on the basis of infection or vaccination history and compared to respiratory syncytial viral or allergen (eg, cockroach, dust mite)-specific immunity...
May 2024: J Allergy Clin Immunol Glob
https://read.qxmd.com/read/38589874/plasmodium-falciparum%C3%A2-genetic-diversity-and-multiplicity-of-infection-based-on-msp-1-msp-2-glurp-and-microsatellite-genetic-markers-in-sub-saharan-africa-a-systematic-review-and-meta-analysis
#43
REVIEW
Alex Mwesigwa, Moses Ocan, Benson Musinguzi, Rachel Wangi Nante, Joaniter I Nankabirwa, Steven M Kiwuwa, Alison Annet Kinengyere, Barbara Castelnuovo, Charles Karamagi, Ekwaro A Obuku, Samuel L Nsobya, Sam M Mbulaiteye, Pauline Byakika-Kibwika
BACKGROUND: In sub-Saharan Africa (SSA), Plasmodium falciparum causes most of the malaria cases. Despite its crucial roles in disease severity and drug resistance, comprehensive data on Plasmodium falciparum genetic diversity and multiplicity of infection (MOI) are sparse in SSA. This study summarizes available information on genetic diversity and MOI, focusing on key markers (msp-1, msp-2, glurp, and microsatellites). The systematic review aimed to evaluate their influence on malaria transmission dynamics and offer insights for enhancing malaria control measures in SSA...
April 8, 2024: Malaria Journal
https://read.qxmd.com/read/38589401/a-live-attenuated-vaccine-to-prevent-severe-neonatal-escherichia-coli-k1-infections
#44
JOURNAL ARTICLE
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
Preterm birth is currently the leading cause of neonatal morbidity and mortality. Genetic, immunological and infectious causes are suspected. Preterm infants have a higher risk of severe bacterial neonatal infections, most of which are caused by Escherichia coli an in particular E. coli K1strains. Women with history of preterm delivery have a high risk of recurrence and therefore constitute a target population for the development of vaccine against E. coli neonatal infections. Here, we characterize the immunological, microbiological and protective properties of a live attenuated vaccine candidate in adult female mice and their pups against after a challenge by K1 and non-K1 strains of E...
April 8, 2024: Nature Communications
https://read.qxmd.com/read/38586190/comparative-development-of-the-serotonin-and-fmrfamide-immunoreactive-components-of-the-nervous-system-in-two-distantly-related-ribbon-worm-species-nemertea-spiralia
#45
JOURNAL ARTICLE
Jörn von Döhren
INTRODUCTION: Neurodevelopment in larval stages of non-model organisms, with a focus on the serotonin- and FMRFamide-immunoreactive components, has been in the focus of research in the recent past. However, some taxonomic groups remain understudied. Nemertea (ribbon worms) represent such an understudied clade with only few reports on nervous system development mostly from phylogenetically or developmentally derived species. It would be insightful to explore neurodevelopment in additional species to be able to document the diversity and deduce common patterns to trace the evolution of nervous system development...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38583823/a-severe-case-of-plasmodium-falciparum-malaria-in-a-traveler-returning-from-kazakhstan-a-malaria-free-country
#46
Thirumalaisamy P Velavan, Wim A Fleischmann, Peter G Kremsner
Following a two-weeks trip to Kazakhstan, a 42-year-old woman presented at the emergency department in Germany with fever, headache, nausea, and neurological symptoms. An infection with Plasmodium falciparum was rapidly diagnosed. The patient was immediately treated with intravenous artesunate and transferred to an intensive care unit. The initial parasite density was as high as 30% infected erythrocytes with 845880 parasites/µL. Since Kazakhstan was declared malaria-free in 2012, molecular testing for Plasmodium has been initiated to identify a possible origin...
April 5, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38582837/genotyping-plasmodium-falciparum-gametocytes-using-amplicon-deep-sequencing
#47
JOURNAL ARTICLE
Jimmy Vareta, Natalie A Horstman, Matthew Adams, Karl B Seydel, Robert S McCann, Lauren M Cohee, Miriam K Laufer, Shannon Takala-Harrison
BACKGROUND: Understanding the dynamics of gametocyte production in polyclonal Plasmodium falciparum infections requires a genotyping method that detects distinct gametocyte clones and estimates their relative frequencies. Here, a marker was identified and evaluated to genotype P. falciparum mature gametocytes using amplicon deep sequencing. METHODS: A data set of polymorphic regions of the P. falciparum genome was mined to identify a gametocyte genotyping marker...
April 6, 2024: Malaria Journal
https://read.qxmd.com/read/38580450/deletion-of-ptp4a3-phosphatase-in-high-grade-serous-ovarian-cancer-cells-decreases-tumorigenicity-and-produces-marked-changes-in-intracellular-signaling-pathways-and-cytokine-release
#48
JOURNAL ARTICLE
John S Lazo, Kelly N Isbell, Sai Ashish Vasa, Danielle C Llaneza, Garnett A Mingledorff, Elizabeth R Sharlow
The oncogenic protein tyrosine phosphatase PTP4A3 is frequently overexpressed in human ovarian cancers and is associated with poor patient prognosis. PTP4A3 is thought to regulate multiple oncogenic signaling pathways, including STAT3, SRC, and ERK. The objective of this study was to generate ovarian cancer cells with genetically depleted PTP4A3; to assess their tumorigenicity; to examine their cellular phenotype; and to uncover changes in their intracellular signaling pathways and cytokine release profiles...
April 5, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38574703/development-and-validation-of-streptavidin-biotin-based-double-antibody-sandwich-elisa-for-ricin-diagnosis
#49
JOURNAL ARTICLE
Shivani Dixit, Jagrati Parashar, Ram Kumar Dhaked, Abdhesh Kumar, Nandita Saxena
BACKGROUND: Ricin is a potential biowarfare agent. It is a phytotoxin isolated from castor seeds. At present there is no antidote available for ricin poisoning, patients only get supportive treatment based on their symptoms. This highlights the importance of early detection to avoid severity of accidents and reduce the risk factor. Considering this, our study aimed to develop a highly sensitive and specific sandwich ELISA for the detection of ricin. METHODS: Ricin was purified from castor seeds...
April 3, 2024: International Immunopharmacology
https://read.qxmd.com/read/38574460/development-of-a-colloidal-gold-immunochromatographic-strip-for-rapid-detection-of-avian-coronavirus-infectious-bronchitis-virus
#50
JOURNAL ARTICLE
Chang-Run Zhao, Li-Ting Lin, Jin-Wen Tang, Yu Zhang, Wen Zhang, Ji-Ming Chen, Ping Wei, Teng Huang, Tian-Chao Wei, Mei-Lan Mo
Avian infectious bronchitis virus (IBV) still causes serious economic losses in the poultry industry. Currently, there are multiple prevalent genotypes and serotypes of IBVs. It is imperative to develop a new diagnosis method that is fast, sensitive, specific, simple, and broad-spectrum. A monoclonal hybridoma cell, N2D5, against the IBV N protein was obtained after fusion of myeloma SP2/0 cells with spleen cells isolated from the immunized Balb/c mice. The N2D5 monoclonal antibody (mAb) and the previously prepared mouse polyclonal antibody against the IBV N protein were used to target IBV as a colloidal gold-mAb conjugate and a captured antibody, respectively, in order to develop an immunochromatographic strip...
March 23, 2024: Poultry Science
https://read.qxmd.com/read/38574299/cd4-car-t-cell-exhaustion-associated-with-early-relapse-of-multiple-myeloma-after-bcma-car-t-cell-therapy
#51
JOURNAL ARTICLE
Guy Ledergor, Zenghua Fan, Kai Wu, Elizabeth McCarthy, Axel Hyrenius-Wittsten, Alec Starzinski, Hewitt Chang, Mark Bridge, Serena S Kwek, Alexander Cheung, Sophia Anna Bylsma, Erik Hansen, Jeffrey Lee Wolf, Sandy W Wong, Nina Shah, Kole T Roybal, Thomas G Martin, Chun Jimmie Ye, Lawrence Fong
Multiple myeloma is characterized by frequent clinical relapses following conventional therapy. Recently, chimeric antigen receptor T (CAR-T) cells targeting B-cell maturation antigen (BCMA) has been established as a treatment option for patients with relapsed or refractory disease. However, while >70% of patients initially respond to this treatment, clinical relapse and disease progression occur in most cases. Recent studies showed persistent expression of BCMA at the time of relapse, indicating that immune intrinsic mechanisms may contribute to this resistance...
April 4, 2024: Blood Advances
https://read.qxmd.com/read/38573620/dose-related-side-effects-of-intravitreal-injections-of-humanized-anti-vascular-endothelial-growth-factor-in-rats-glial-cell-reactivity-and-retinal-ganglion-cell-loss
#52
JOURNAL ARTICLE
Ana Martínez-Vacas, Johnny Di Pierdomenico, Ana María Gómez-Ramirez, Manuel Vidal-Sanz, María P Villegas-Pérez, Diego García-Ayuso
PURPOSE: In a previous study, we documented that the Intravitreal injections (IVIs) of bevacizumab in rats caused a retinal inflammatory response. We now study whether the IVI of other humanized anti-VEGF: ranibizumab and aflibercept also cause an inflammatory reaction in the rat retina and if it depends on the dose administered. Finally, we study whether this reaction affects retinal ganglion cell (RGC) survival. METHODS: Albino Sprague-Dawley rats received a single IVI of 5 µL of PBS or ranibizumab or aflibercept at the concentration used in clinical practice (10 µg/µL or 40 µg/µL) or at a lower concentration (0...
April 1, 2024: Investigative Ophthalmology & Visual Science
https://read.qxmd.com/read/38573563/alk-positive-large-b-cell-lymphoma-alk%C3%A2-%C3%A2-lbcl-with-aberrant-cd3-expression
#53
JOURNAL ARTICLE
Jess Baker, Sara L Zadeh, Nadine S Aguilera
ALK-positive ( +) large B cell lymphoma (ALK + LBCL) is a rare distinct subtype of diffuse large B cell lymphoma presenting with high stage and aggressive behavior. Although B cell markers such as CD20, CD19, and CD22 are generally negative, plasmacytic markers including CD138, CD38, and MUM1 are positive. T cell markers are negative with rare exceptions. We report an unusual case of ALK1 + LBCL in a 58-year-old man with partial expression of CD3 without other T cell antigen expression...
April 4, 2024: Journal of Hematopathology
https://read.qxmd.com/read/38573322/impatient-qpcr-monitoring-selex-success-during-in-vitro-aptamer-evolution
#54
JOURNAL ARTICLE
Ann-Kathrin Kissmann, Grigory Bolotnikov, Runliu Li, Franziska Müller, Hu Xing, Markus Krämer, Kay-E Gottschalk, Jakob Andersson, Tanja Weil, Frank Rosenau
SELEX (Systematic Evolution of Ligands by Exponential enrichment) processes aim on the evolution of high-affinity aptamers as binding entities in diagnostics and biosensing. Aptamers can represent game-changers as constituents of diagnostic assays for the management of instantly occurring infectious diseases or other health threats. Without in-process quality control measures SELEX suffers from low overall success rates. We present a quantitative PCR method for fast and easy quantification of aptamers bound to their targets...
April 4, 2024: Applied Microbiology and Biotechnology
https://read.qxmd.com/read/38572528/diagnosing-adult-and-pediatric-extrapulmonary-tuberculosis-by-mpt64-antigen-detection-with-immunohistochemistry-and-immunocytochemistry-using-reproduced-polyclonal-antibodies
#55
JOURNAL ARTICLE
Ole Magnus Bjørgaas Helle, Mala Kanthali, Sheeba Ishtiaq, Atiqa Ambreen, Manju Raj Purohit, Tehmina Mustafa
Diagnosing extrapulmonary tuberculosis (EPTB) is challenging. Immunohistochemistry or immunocytochemistry has been used to diagnose tuberculosis (TB) by detection of MPT64 antigen from various extrapulmonary specimens and has shown good diagnostic performance in our previous studies. The test can distinguish between disease caused by Mycobacterium tuberculosis (Mtb) complex and nontuberculous mycobacteria and can be applied on formalin-fixed paraffin-embedded tissue. As the antibodies previously used were in limited supply, a new batch of polyclonal antibodies was developed for scale-up and evaluated for the first time in this study...
May 2024: Journal of Pathology. Clinical Research
https://read.qxmd.com/read/38570436/cross-reactive-polyclonal-antibodies-raised-against-galnac-conjugated-sirna-recognize-mostly-the-galnac-moiety
#56
JOURNAL ARTICLE
Kimberly K Ballman, Victoria L Peek, John H Sloan, Jingling Li, Robert J Konrad, Yi Wen
Small interfering RNA (siRNA) is gaining momentum as a therapeutic modality with six approved products. Since siRNA has the potential to elicit undesired immune responses in patients, immunogenicity assessment is required during clinical development by regulatory authorities. In this study, anti-siRNA polyclonal antibodies were generated through animal immunization. These cross-reactive polyclonal antibodies recognized mostly the N-acetylgalactosamine (GalNAc) moiety with a small fraction against sequence-independent epitopes...
April 3, 2024: AAPS Journal
https://read.qxmd.com/read/38566969/understanding-the-pharmacokinetic-journey-of-fc-fusion-protein-rhil-7-hyfc-using-complementary-approach-of-two-analytical-methods-accelerator-mass-spectrometry-and-elisa
#57
JOURNAL ARTICLE
Anhye Kim, Min-Seok Oh, Gwan-Ho Lee, Seongeun Song, Mi-Sun Byun, Donghoon Choi, Byung-Yong Yu, Howard Lee
Antibody-based therapeutics (ABTs), including monoclonal/polyclonal antibodies and fragment crystallizable region (Fc)-fusion proteins, are increasingly used in disease treatment, driving the global market growth. Understanding the pharmacokinetic (PK) properties of ABTs is crucial for their clinical effectiveness. This study investigated the PK profile and tissue distribution of efineptakin alfa, a long-acting recombinant human interleukin-7 (rhIL-7-hyFc), using enzyme-linked immunosorbent assay (ELISA) and accelerator mass spectrometry (AMS)...
April 2024: Antibody Therapeutics
https://read.qxmd.com/read/38562884/timing-of-treatment-shapes-the-path-to-androgen-receptor-signaling-inhibitor-resistance-in-prostate-cancer
#58
Eugine Lee, Zeda Zhang, Chi-Chao Chen, Danielle Choi, Aura C Agudelo Rivera, Eliot Linton, Yu-Jui Ho, Jillian Love, Justin LaClair, John Wongvipat, Charles L Sawyers
There is optimism that cancer drug resistance can be addressed through appropriate combination therapy, but success requires understanding the growing complexity of resistance mechanisms, including the evolution and population dynamics of drug-sensitive and drug-resistant clones over time. Using DNA barcoding to trace individual prostate tumor cells in vivo , we find that the evolutionary path to acquired resistance to androgen receptor signaling inhibition (ARSI) is dependent on the timing of treatment. In established tumors, resistance occurs through polyclonal adaptation of drug-sensitive clones, despite the presence of rare subclones with known, pre-existing ARSI resistance...
March 20, 2024: bioRxiv
https://read.qxmd.com/read/38562795/canopy2-tumor-phylogeny-inference-by-bulk-dna-and-single-cell-rna-sequencing
#59
Ann Marie K Weideman, Rujin Wang, Joseph G Ibrahim, Yuchao Jiang
Tumors are comprised of a mixture of distinct cell populations that differ in terms of genetic makeup and function. Such heterogeneity plays a role in the development of drug resistance and the ineffectiveness of targeted cancer therapies. Insight into this complexity can be obtained through the construction of a phylogenetic tree, which illustrates the evolutionary lineage of tumor cells as they acquire mutations over time. We propose Canopy2, a Bayesian framework that uses single nucleotide variants derived from bulk DNA and single-cell RNA sequencing to infer tumor phylogeny and conduct mutational profiling of tumor subpopulations...
March 19, 2024: bioRxiv
https://read.qxmd.com/read/38559180/anti-immune-complex-antibodies-are-elicited-during-repeated-immunization-with-hiv-env-immunogens
#60
Sharidan Brown, Aleksandar Antanasijevic, Leigh M Sewall, Daniel Montiel Garcia, Philip J M Brouwer, Rogier W Sanders, Andrew B Ward
UNLABELLED: Vaccination strategies against HIV-1 aim to elicit broadly neutralizing antibodies (bnAbs) using prime-boost regimens with HIV envelope (Env) immunogens. Early antibody responses to easily accessible epitopes on these antigens are directed to non-neutralizing epitopes instead of bnAb epitopes. Autologous neutralizing antibody responses appear upon boosting once immunodominant epitopes are saturated. Here we report another type of antibody response that arises after repeated immunizations with HIV Env immunogens and present the structures of six anti-immune complexes discovered using polyclonal epitope mapping...
March 17, 2024: bioRxiv
keyword
keyword
168322
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.